Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

417
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
417
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
134
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

131
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
131
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

358
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

427
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choledochoduodenal fistula paradoxically prevents biliary obstruction: a case report.

Frontiers in surgery·2026
Same author

Effects of diet, dietary inflammatory index, modified antiinflammatory dietary intervention via diet management platform on short-term prognosis in patients with ulcerative colitis: A prospective study.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

When the Gut Tells a Different Story: A Case of Persistent Enteropathy in a Teenager.

Gastroenterology·2026
Same author

A mixed methods study of multidisciplinary team assessment and therapeutic decision making for intestinal strictures in Crohn's disease.

Scientific reports·2026
Same author

Optimizing steroid treatment for UC patients with CMV colitis: a multicenter real-world study.

Virology journal·2025
Same author

Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: findings from the Global Burden of Disease 2021.

Gastroenterology report·2025

Related Experiment Video

Updated: Jun 16, 2025

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
08:52

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

4.4K

Deep mucosal healing in ulcerative colitis: how deep is better?

Xin Jin1, Yan You2, Gechong Ruan1

  • 1Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Frontiers in Medicine
|August 19, 2024
PubMed
Summary

Achieving mucosal healing (MH) is crucial for ulcerative colitis (UC) long-term remission. Current definitions of deep MH lack standardization, necessitating further research for improved patient outcomes.

Keywords:
clinical practicedeep mucosal healingendoscopic remissionhistological remissionulcerative colitis

More Related Videos

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.4K
Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
09:42

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation

Published on: August 26, 2014

18.6K

Related Experiment Videos

Last Updated: Jun 16, 2025

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
08:52

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

4.4K
Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.4K
Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
09:42

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation

Published on: August 26, 2014

18.6K

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Trial Design

Background:

  • Ulcerative colitis (UC) significantly impacts patient quality of life due to its recurrent nature.
  • Clinical remission alone is insufficient for sustained long-term remission in UC.
  • Mucosal healing (MH) is increasingly recognized as a critical therapeutic target in UC management.

Purpose of the Study:

  • To critically review and analyze the evolving definitions of deep mucosal healing (MH) in ulcerative colitis (UC).
  • To examine the strengths and limitations of various endoscopic and histological scoring systems for assessing MH.
  • To highlight the current lack of a universal, standardized definition for deep MH in clinical practice.

Main Methods:

  • Comprehensive literature review of studies defining and assessing mucosal healing in UC.
  • Analysis of existing endoscopic and histological scoring systems.
  • Evaluation of the impact of advanced technologies on deep MH assessment.

Main Results:

  • Endoscopic remission (ER) is widely used but subjective; histological remission (HR) shows promise for reducing flares but lacks routine incorporation.
  • Advanced technologies are enhancing the definition of deep MH.
  • A universally standardized definition for deep MH in clinical practice is currently absent.

Conclusions:

  • The definition of deep mucosal healing (MH) in ulcerative colitis (UC) requires further standardization.
  • Standardized definitions and validation through large-scale trials are essential to realize the full benefits of deep MH for UC patients.
  • Future research should focus on validating a universal definition of deep MH to guide therapy and improve long-term prognosis.